ChromoGenics communicates order data for the fourth quarter in 2023 and postpones publication of the year-end report for 2023.
ChromoGenics order intake for the fourth quarter 2023 amounted to 6,6 MSEK and the order book for the same period was 11,5 MSEK.
Due to unexpected administrative reasons, the Board of Directors of ChromoGenics has decided to postpone the publication of the year-end report for 2023 until 8th of March 2024. Previously communicated date for submission of the report was on the 20th of February 2024.
Full data on the fourth quarter 2023 will be published in the year-end report.
Contact:
Fredrik Fränding, CEO
Anne-Marie Gullman, CFO & Head of Investor Relations
Tel: +46 (0) 18 430 0430
E-mail: info@chromogenics.com